SightfileU.S. market data from official filings

CARLSMED INC (CARL)

Name: CARLSMED INC (CARL) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001794546 · EDGAR filings · Updated 2026-06-22

CARLSMED INC (CARL) has reported institutional ownership of 19.5%, with 66 institutional managers holding positions valued at $48.0M per the latest 13F reporting period.

Institutional ownership

19.5%

Institutional managers

Reported 13F value

$48.0M

Insider activity

42 trans.

$45.5M net buying

Latest updates

2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-22 — Insider transaction reported (Form 4)
2026-06-03 — Current report (8-K) filed
2026-05-05 — Quarterly report (10-Q) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CARLSMED INC has 66 institutional holders and institutional ownership of 19.5%.

Insider activity

Insiders reported 42 transactions (6 buys, 1 sells) across 11 reporting insiders, with a net reported value of $45.5M.

Related companies

MESOBLAST LTD (MESO) · SPRUCE BIOSCIENCES INC COM NEW (SPRB) · Spero Therapeutics Inc (SPRO) · Assertio Holdings Inc (ASRT) · MAXCYTE INC (MXCT) · PMV PHARMACEUTICALS INC (PMVP)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.